HEK-Dual™ HTLR9 (NF/IL8) Reporter Cells - InvivoGen

Skip to main content
  1. Products
  2. Cell Lines
  3. HEK293 embryonic kidney cell lines
  4. HEK293 TLR Reporter Cells
  5. Human TLR9 Dual Reporter HEK 293 Cells (NF-κB & IRF)
Human TLR9 Dual Reporter HEK 293 Cells (NF-κB & IRF)

NF-κB-SEAP & IRF-Lucia reporter cells

NF-κB responses of HEK-Blue™ hTLR9 vs. HEK-Dual™ hTLR9 NF-κB responses in hTLR9-expressing HEK-Dual™ -derived cells IRF responses in hTLR9-expressing HEK-Dual™-derived cells

HEK-Dual™ hTLR9 Cells

  • Cat.code: hkd-htlr9
  • Documents
  • Add to favorites
  • Customer support
$1,728 Cell format TLR9 CellsAdditional vial * Unit Size 3-7 x 10^6 cells Quantity *Save on additional vials when you buy the matching cell reference. Bulk / Custom order Need a quote?
  • Documents
  • Support
  • Add to favorites

ABOUT

NF-κB–SEAP and IRF–Lucia reporter HEK293 cells expressing human TLR9

HEK-Dual™ hTLR9 cells were were engineered from HEK-Dual™ cells, a human embryonic kidney HEK293-derived cell line, to study the Toll-like receptor 9 (TLR9)-dependent NF-κB and IRF pathway. This important pattern recognition receptor (PRR) recognizes unmethylated CpG dinucleotides, a hallmark of microbial or host-derived self DNA, and subsequently triggers NF-κB and IRF immune responses [1].

More details More details

Description

HEK-Dual™ hTLR9 cells feature the stable expression of the human TLR9 gene as well as two inducible reporter genes for SEAP (secreted embryonic alkaline phosphatase) and Lucia luciferase. As a result, these cells allow the simultaneous study of the NF-κB pathway, by monitoring the activity of SEAP, and the IRF pathway, by assessing the activity of the secreted Lucia luciferase. Upon TLR9 activation, both reporter proteins are readily measurable in the cell culture supernatant when using QUANTI-Blue™ Solution, a SEAP detection reagent, and QUANTI-Luc™ 4 Lucia/Gaussia, a Lucia luciferase detection reagent.

HEK-Dual™ hTLR9 cells are highly responsive to TLR9 agonists, such as oligonucleotides containing CpG motifs (CpG ODNs). They show potent NF-κB and IRF responses upon incubation of CpG-ODNs of class A (e.g. ODN 2216), class B (e.g. ODN 2006), and class C (e.g. ODN 2395), when compared to their parental cell line HEK-Dual™ (see figures).

Of note, HEK293 cells express endogenous levels of various PRRs, including TLR3, TLR5, and RIG-I-like receptors, and therefore might respond to their cognate ligands.

Key features

  • Stable expression of human TLR9
  • Strong response to synthetic DNA containing CpG motifs
  • Distinct monitoring of TLR9-dependent NF-κB or IRF activation by assessing the SEAP and Lucia luciferase activities

Applications

  • Defining the role of TLR9-dependent IRF and NF-κB signaling pathways
  • Screening for novel TLR9 agonists and inhibitors in comparison with their parental cell line HEK-Dual™

Reference

1. Kumagai Y. et al., 2008. TLR9 as a key receptor of the recognition of DNA. Adv. Drug. Deliv. Rev. 60(7):795-804.

Disclaimer: These cells are for internal research use only and are covered by a Limited Use License (See Terms and Conditions). Additional rights may be available.

Image Signaling pathways in HEK-Dual™ hTLR9 cells Signaling pathways in HEK-Dual™ hTLR9 cells

SPECIFICATIONS

Specifications

Target

TLR9

Target species

Human

Tested applications

Dual reporter assays for TLR9 pathway, NF-κB and IRF signaling pathways

Cell type Epithelial Growth properties Adherent Tissue origin Human embryonic kidney cells Reporter gene Lucia® Detection method Colorimetric (SEAP), Bioluminescence (Lucia) Antibiotic resistance Blasticidin Hygromycin Puromycin Zeocin® Growth medium

Complete DMEM (see TDS)

Mycoplasma-free

Verified using Plasmotest™

Quality control

Each lot is functionally tested and validated.

CONTENTS

Contents

  • Product: HEK-Dual™ hTLR9 Cells
  • Cat code: hkd-htlr9
  • Quantity: 3-7 x 10^6 cells
Includes:
  • 1 ml Blasticidin (10 mg/ml)
  • 1 ml Hygromycin B Gold (100 mg/ml)
  • 1 ml Puromycin (10 mg/ml)
  • 1 ml Zeocin® (100 mg/ml)
  • 1 ml Normocin™ (50 mg/ml)
  • 1 tube of QUANTI-Luc™ 4 Reagent (sufficient to prepare 25 ml)
  • 1 ml of QB reagent and 1 ml of QB buffer (sufficient to prepare 100 ml of QUANTI-Blue™ Solution)

Shipping & Storage

  • Shipping method: Dry ice
  • Storage:

    • Liquid nitrogen vapor
    Stability: 20 passages

    Caution:

    • Upon receipt, store immediately in liquid nitrogen vapor. Do not store cell vials at -80°C.

Details

Toll-Like Receptor 9 (TLR9) is an endosomal receptor that triggers NF-κB- and IRF-mediated pro-inflammatory responses upon the recognition of unmethylated cytosine-phosphorothioate-guanosine (CpG) forms of DNA [1-3]. Unmethylated CpG dinucleotides are a hallmark of microbial (bacterial, viral, fungal, and parasite) DNA, as well as mitochondrial self-DNA [3,4]. These TLR9 agonists can be mimicked by synthetic oligonucleotides containing CpG motifs (CpG ODNs), which have been extensively studied to improve adaptive immune responses in the context of vaccination [1,3].

TLR9 is mainly expressed in subsets of Dendritic Cells and in B cells of all mammals. In rodents, but not in humans, TLR9 is also expressed in monocytes and macrophages [3]. The structure of the receptor varies by 24% between human TLR9 (hTLR9) and mouse TLR9 (mTLR9) [3]. They recognize different CpG motifs, the optimal sequences being GTCGTT and GACGTT for hTLR9 and mTLR9, respectively [5].

Get more information about CpG-ODNs Classes.

References

1. Kumagai Y. et al., 2008. TLR9 as a key receptor of the recognition of DNA. Adv. Drug. Deliv. Rev. 60(7):795-804.2. Heinz L.X. et al., 2021. TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7-9. Nature. 581(7808):316-322.3. Kayraklioglu N. et al., 2021. CpG oligonucleotides as vaccine adjuvants. DNA Vaccines: Methods and Protocols. Methods in Molecular Biology. Vol. 2197. p51-77.4. Kumar V., 2021. The trinity of cGAS, TLR9, and ALRs: guardians of the cellular galaxy against host-derived self-DNA. Front. Immunol. 11:624597.5. Bauer S. et al., 2001. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc Natl Acad Sci USA, 98(16):9237-42.

DOCUMENTS

Documents

HEK-Dual™ hTLR9 Cells

Technical Data Sheet

View document

Validation Data Sheet

View document

Safety Data Sheet

View document

Certificate of analysis

Need a CoA ?

Contact us

You may also need

Cell Lines

Human TLR9 Dual Reporter THP-1 Cells

Validation of TLR9 overexpression

NF-κB-SEAP and IRF-Lucia reporter monocytes

1 product from $1,906 VIEW

Cell Lines

NF-κB and ISG Dual Reporter HEK 293 Cells - HEK-Dual™ Cells

NF-κB response of HEK-Dual™ cells to various PRR agonists and cytokines

NF-κB-SEAP and IRF-Lucia Reporter Cells

1 product from $1,584 VIEW

Vaccination

ODN 2006 VacciGrade™ - TLR9-based Adjuvant

Species-driven TLR9 differential responses

CpG ODN, Class B (Human) | Th1 response

1 product from $1,008 VIEW

Reporter Detection Reagents

QUANTI-Blue™ - SEAP Detection Reagent

QUANTI-Blue™ Standard procedure

Alkaline phosphatase detection reagent

1 product from $240 VIEW

Reporter Detection Reagents

QUANTI-Luc™: Luciferase Detection Reagent

Lucia luciferase detection for 10 min using QUANTI-Luc™ 4 Lucia/Gaussia

Luminescence detection kit for standard and HTS assays

2 products from $194 VIEW

Antibiotics Contamination

Normocin® - Antimicrobial Reagent

Normocin™ by InvivoGen

For preventing contamination of cell cultures by mycoplasma...

1 product from $133 VIEW

Antibiotics Selection

Blasticidin

Blasticidin Solution by InvivoGen

Selective antibiotic for the bsr, bls, or BSD genes

2 products from $207 VIEW

Antibiotics Selection

Puromycin

Puromycin by InvivoGen

Selective antibiotic for the pac gene

1 product from $164 VIEW

CUSTOMER SERVICE & TECHNICAL SUPPORT

Question about this product ?

- Select -Bulk / Custom ordersBusiness Development & LicensingCustomer serviceGeneral informationOutlicensingTechnical supportWebsite bug report - Select -AfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua & BarbudaArgentinaArmeniaArubaAscension IslandAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBosnia & HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBritish Virgin IslandsBruneiBulgariaBurkina FasoBurundiCambodiaCameroonCanadaCanary IslandsCape VerdeCaribbean NetherlandsCayman IslandsCentral African RepublicCeuta & MelillaChadChileChinaChristmas IslandClipperton IslandCocos (Keeling) IslandsColombiaComorosCongo - BrazzavilleCongo - KinshasaCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzechiaCôte d’IvoireDenmarkDiego GarciaDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatiniEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard & McDonald IslandsHondurasHong Kong SAR ChinaHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKosovoKuwaitKyrgyzstanLaosLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacao SAR ChinaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmar (Burma)NamibiaNauruNepalNetherlandsNetherlands AntillesNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorthern Mariana IslandsNorth KoreaNorth MacedoniaNorwayOmanOutlying OceaniaPakistanPalauPalestinian TerritoriesPanamaPapua New GuineaParaguayPeruPhilippinesPitcairn IslandsPolandPortugalPuerto RicoQatarRomaniaRussiaRwandaRéunionSamoaSan MarinoSarkSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia & South Sandwich IslandsSouth KoreaSouth SudanSpainSri LankaSt. BarthélemySt. HelenaSt. Kitts & NevisSt. LuciaSt. MartinSt. Pierre & MiquelonSt. Vincent & GrenadinesSudanSurinameSvalbard & Jan MayenSwedenSwitzerlandSyriaSão Tomé & PríncipeTaiwanTajikistanTanzaniaThailandTimor-LesteTogoTokelauTongaTrinidad & TobagoTristan da CunhaTunisiaTurkmenistanTurks & Caicos IslandsTuvaluTürkiyeU.S. Outlying IslandsU.S. Virgin IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVatican CityVenezuelaVietnamWallis & FutunaWestern SaharaYemenZambiaZimbabweÅland Islands

Từ khóa » H-293-8